Purespet | OEM/ODM Pet Health Monitor and GPS Tracker Development Partner
French Bulldog owners spent more on veterinary care in 2024 than owners of any other breed. Pet PetSure’s 2025 Pet Health Monitor report, that number is $1,641 per year, per dog. Pugs and Bulldogs are not far behind.
French Bulldog and Pug owners are not overspending because they are careless. They are spending because their dogs have specific build. In scientific terms: their dogs have compressed airways, narrowed nostrils, and soft palates that do not fit the skulls they were bred into. In real-life terms, they have trouble breathing because their build.
The brachycephalic dog population is enormous, growing, and medically complex. One of the main challenges for these dogs is Brachycephalic Obstructive Airway Syndrome (BOAS), which can affect an estimated 50% or more of dogs in extreme brachycephalic breeds, according to a large-scale study from the University of Cambridge. Yet the pet health device market still treats these dogs the same as every other breed.
There is an opportunity for pet health companies. And we are here to explore it.
The French Bulldog became the most popular puppy breed in the UK, according to the Royal Veterinary College's VetCompass programme, which analyzed over 2.2 million dogs in first-opinion veterinary care. In the United States, the French Bulldog topped the American Kennel Club's registration rankings in 2022 and has held that position since. The Bulldog and Pug consistently rank in the top 15.
These three breeds share a defining structural feature: a shortened skull that compresses the entire upper airway. That compression comes with costs. The Humane Society Veterinary Medical Association reported that upper respiratory disorders were the cause of death for 17% of dogs with extreme brachycephalic conformation, compared to 0% for all other breeds. The average lifespan of these extreme brachycephalic dogs is 8.6 years, versus 12.7 years for all other breeds.
A 2019 PLOS One study surveyed 2,168 owners of Pugs, French Bulldogs, and Bulldogs. Despite the fact that one-fifth reported their dog had undergone at least one conformation-related surgery, 70.9% considered their dog to be in very good or the best health possible. That difference between owner perception and clinical reality is where companies can find new customers. These owners love their dogs deeply. They spend freely. And they do not always recognize when their dog is struggling to breathe.
Brachycephalic Obstructive Airway Syndrome is not one problem. It is a series of problems.
The shortened skull compresses the nasal passages, narrows the nostrils (stenotic nares), and leaves a soft palate that is too long for the space it occupies. A 2025 study published in Frontiers in Veterinary Science reviewed 80 brachycephalic dogs that required surgical intervention for BOAS between 2018 and 2022, documenting a high prevalence of laryngeal collapse as a secondary consequence of chronic airway obstruction.
The clinical signs are specific: inspiratory stertor (a low-pitched snoring sound even while awake), stridor (a higher-pitched wheeze), exercise intolerance, regurgitation, vomiting, episodes of syncope (fainting), and dyspnea (difficulty breathing). A study from the National Taiwan University found that 74% of brachycephalic dogs present with both respiratory and gastrointestinal symptoms simultaneously.
A 2026 cross-sectional study from Cambridge, published in PLOS One, assessed nearly 900 dogs across 14 brachycephalic breeds. The researchers found that BOAS prevalence varies considerably between breeds but that Pugs, French Bulldogs, and Bulldogs had some of the lowest proportions of clinically unaffected (Grade 0) dogs: just 7%, 10%, and 10.9% respectively.
The problem does not stay in the airway. Chronic respiratory obstruction puts strain on the cardiovascular system. Untreated BOAS can lead to pulmonary vasoconstriction, pulmonary hypertension, and right-sided heart failure. A dog that sounds like it is snoring on the couch may be developing cardiac disease.
This is where hardware enters the picture. A brachycephalic dog's respiratory rate at rest is one of the earliest and most reliable signals of disease progression. A healthy dog breathes 10 to 30 times per minute while resting. Consistently exceeding 30 breaths per minute is a red flag that Cornell University's College of Veterinary Medicine identifies as requiring immediate evaluation. For brachycephalic breeds, that threshold matters more, because their compromised airways mean they are already working harder to breathe at baseline.
Veterinary cardiologists already prescribe home respiratory rate monitoring. It is the single most important home-monitored variable for dogs with heart disease. But the method? Count your dog’s breaths per minute while they are resting or sleeping. Do it every night, write it down, and pay attention to the number. If it goes above 30, call the clinic.
Now imagine if you can offer something to these owners, who are kneeling beside their sleeping dog, watching their rib cage rise and fall with a timer on their phone. For brachycephalic breeds, the problem brings even more challenges. They already have audible breathing at rest. The sounds that would trigger alarm in a Labrador are background noise in a French Bulldog.
Owners call it “normal” for a French bulldog to snore. And there lies the problem. What vets prescribe and what owners can reliably do at home is where the next generation of pet health products will come.
Ballistocardiography (BCG) is a noninvasive method that measures the mechanical forces generated by the heart itself. It was first described by Gordon in 1877 and has been used in human medicine for decades. The principle is direct: when the heart contracts and pushes blood through the vessels, the body produces microscopic movements. A BCG sensor detects those movements.
A 2025 peer-reviewed study published in Veterinary Sciences evaluated a BCG wearable device for monitoring heart rate and respiratory rate in dogs, comparing it against the gold-standard ECG. Under awake conditions, BCG showed a strong correlation with ECG for both heart rate and respiratory rate. Under anesthesia, the correlation remained significant (heart rate: r = 0.96, R-squared = 0.92; respiratory rate: r = 0.85, R-squared = 0.72). The researchers concluded that BCG technology is a viable alternative for continuous, noninvasive vital sign monitoring in clinical and home settings.
The distinction matters for brachycephalic breeds specifically. A chest-wall motion sensor estimates respiratory rate by watching the outside of the body move. BCG captures the cardiac and respiratory signals from the source. That means a BCG device can track resting respiratory rate through fur, without shaving, without electrodes, without requiring the dog to stay perfectly still.
For a French Bulldog that shifts positions every few minutes while sleeping, or a Pug that breathes shallowly due to narrowed airways, that difference is the gap between data and noise.
A BCG waveform also carries additional clinical information beyond heart rate and respiratory rate: heart rate variability (HRV), cardiac contractility indicators, and sleep quality data. HRV in particular has documented relevance for detecting early cardiovascular changes. The AI-COLLAR study (Chetboul et al., 2025, published in Frontiers in Veterinary Science), which tracked 703 dogs with continuous biometric monitoring, confirmed that breed, body weight, and age all influence resting respiratory rate. A flat-faced three-year-old Bulldog and a lean ten-year-old Whippet do not share a baseline. Breed-specific monitoring requires a device that can build a baseline belonging to one specific dog.
PuresPet (Shenzhen PureS Technology Co., Ltd.) is a smart pet product manufacturer founded in 2016, specializing in the design, development, and production of pet health monitoring devices and GPS tracking collars. The company operates as an OEM/ODM partner, meaning it builds devices that other pet brands sell under their own name.
That positioning matters. PuresPet does not compete with your brand. It builds the hardware your brand puts on shelves.
The company's health monitoring device uses flexible piezoelectric and bone conduction BCG technology that penetrates fur without touching skin. It monitors continuously at over 100 readings per second, 24 hours a day. The device captures:
The device attaches to a collar and transmits data to a companion app. For brands building a brachycephalic-focused product line, the relevant specification is that this is not an accelerometer estimating motion. It is a BCG sensor reading cardiac and respiratory signals directly from the body.
PuresPet offers both light customization (logo, packaging, color) and deep customization (form factor, functionality, companion app design). The company supports full product development partnerships, from prototyping through mass production, with a monthly capacity exceeding 200,000 units. Products carry CE, RoHS, FCC, KC, and Telec certifications.
Who this is built for: Pet brands, veterinary device companies, pet insurance providers, and distributors looking to source or white-label a health monitoring device that tracks real vital signs rather than steps. If you sell anything that touches brachycephalic breed health, weight management, cardiac monitoring, or senior dog care, PuresPet's hardware is the component you build on.
What makes it different from what else is on the market: Most pet wearables on the market are GPS trackers with an activity overlay. They count movement and call it health data. PuresPet's BCG sensor measures the mechanical forces of the heart and the rhythm of breathing. That is the difference between a fitness tracker and a health monitor. PetPace, for example, uses a multi-sensor collar that tracks temperature, pulse, and respiration, and was named IoT Wearable Device of the Year in January 2025. Maven Pet offers a validated respiratory rate tracker that clips to a collar. The competitive landscape is real, and it is growing. PuresPet's play is not the consumer-facing brand. It is the OEM/ODM layer: the company that builds the device another brand sells. If you want to bring a brachycephalic-specific health monitor to market without building the hardware from scratch, this is the starting point.
The global pet health monitoring wearables market reached $3.2 billion in 2025, according to MarketIntelo, and is projected to grow to $9.8 billion by 2034 at a compound annual growth rate of 14.8%. Dogs account for 57% of that revenue. Vital sign monitoring holds 42% of market share by application.
Within that market, the fastest-growing segment is disease and anomaly detection, forecast to rise at a 16.7% CAGR through 2032 (PS Market Research). The broader pet wearable market, valued at $3.14 billion in 2025, is projected to reach $7.23 billion by 2031 (Research and Markets).
But here is what no market report captures in a single data point: there is no major pet tech brand selling a health monitor positioned specifically for brachycephalic breeds.
Not a single major player has claimed the breed-specific monitoring niche. Halo Collar has activity and GPS tracking with general wellness features. PetPace offers multi-metric health monitoring. Maven Pet provides validated respiratory rate tracking. Each of these is a general-purpose device that works across all breeds.
None of them has built a product around the specific needs of an owner who comes home to a Bulldog that sounds different tonight.
Brachycephalic breeds age into compounding risk. The respiratory strain they carry from birth does not get easier as joints stiffen, hearts weaken, and cognitive function declines.
Canine cognitive dysfunction syndrome (CDS) is a degenerative condition in senior dogs that mirrors Alzheimer's disease in humans. Symptoms include disorientation, disrupted sleep-wake cycles, anxiety, changes in social interaction, and loss of previously learned behaviors. Veterinary behaviorists use the DISHAA framework (disorientation, interaction changes, sleep-wake changes, house soiling, activity changes, anxiety) to assess and track progression.
For brachycephalic breeds, the overlap between CDS symptoms and respiratory distress creates a diagnostic challenge. A senior Pug pacing at night could be experiencing cognitive decline, respiratory distress, or both. A Bulldog that stops engaging with the family might be in pain from chronic airway obstruction or losing cognitive function. The behavioral signals overlap. Without continuous physiological data, even an experienced veterinarian has to guess which system is driving the change.
A senior dog health checklist for brachycephalic breeds should include:
This is not a checklist an owner can complete with observation alone. It is a checklist a continuous monitoring device can automate. A BCG-based wearable that records heart rate, respiratory rate, HRV, activity, and sleep patterns across 24-hour cycles gives a veterinarian the longitudinal data needed to distinguish between respiratory decline and cognitive decline in a senior brachycephalic dog.
The clinical value compounds. A device that has been tracking a dog's baseline for months or years can detect the slow, incremental respiratory rate increases that signal chronic disease progression. These are the changes that a nightly manual count misses entirely, because the shift from 22 breaths per minute to 26 happens over weeks, not overnight.
The primary concern is Brachycephalic Obstructive Airway Syndrome (BOAS), which includes stenotic nares (narrowed nostrils), an elongated soft palate, and potential laryngeal collapse. Beyond respiratory obstruction, brachycephalic breeds face elevated risk for overheating and heatstroke (their compressed nasal passages reduce the ability to regulate body temperature), eye problems including corneal ulcers (prominent eyes are more exposed to injury), dental crowding and periodontal disease (shortened jaws leave less room for teeth), skin fold infections (facial wrinkles trap moisture and bacteria), spinal problems, and gastrointestinal issues including chronic regurgitation. A study from the Vienna University of Veterinary Medicine found that 63% of examined brachycephalic dogs had multiple health problems simultaneously.
A healthy dog at rest breathes between 10 and 30 times per minute, according to the American Kennel Club's Chief Veterinary Officer, Dr. Jerry Klein. Brachycephalic breeds often sit at the higher end of that range due to their compressed airways. Any resting respiratory rate consistently above 30 breaths per minute warrants veterinary evaluation, per Cornell University veterinary guidelines. The challenge is that brachycephalic dogs' audible breathing can mask genuine rate increases. Continuous monitoring through a wearable device removes the guesswork.
Many brachycephalic dogs live full, active lives, particularly with attentive management. The key factors are maintaining a healthy weight (obesity dramatically worsens airway obstruction), avoiding extreme heat, limiting strenuous exercise, and monitoring for early signs of BOAS progression. Corrective surgery, including widening the nostrils and shortening the soft palate, can significantly improve breathing in affected dogs. Continuous health monitoring plays an increasing role in early detection, giving veterinarians data to intervene before symptoms become emergencies.
The Humane Society Veterinary Medical Association reports that dogs with extreme brachycephalic conformation have an average lifespan of 8.6 years, compared to 12.7 years for all other breeds. This four-year gap is driven primarily by respiratory, cardiac, and heat-related complications. Early detection and ongoing management of BOAS and its secondary effects is one of the most direct paths to closing that gap.
The traditional method is to count chest-wall rises while your dog is sleeping or deeply relaxed, using a timer for 60 seconds. Record the number daily and watch for upward trends. For brachycephalic breeds, this manual approach is unreliable because their breathing is already noisy and irregular, making it difficult to distinguish normal from abnormal. BCG-based wearable health monitors eliminate this problem by capturing respiratory rate data continuously and automatically, building a personalized baseline for each dog, and alerting when readings shift outside that individual dog's normal range.
Canine cognitive dysfunction syndrome (CDS) is a neurodegenerative condition in senior dogs that produces symptoms similar to Alzheimer's disease in humans: confusion, disrupted sleep, loss of trained behaviors, increased anxiety, and changes in social interaction. In brachycephalic breeds, CDS symptoms overlap with respiratory distress symptoms, making diagnosis harder. A senior Bulldog that paces at night might be cognitively declining or struggling to breathe comfortably. Continuous monitoring of respiratory rate, heart rate, HRV, and activity patterns gives veterinarians the data needed to differentiate between these conditions.
For breeds where breathing difficulty is the leading health risk and the leading cause of death, a device that continuously tracks respiratory rate is not a luxury purchase. It is the difference between catching a problem at 26 breaths per minute and catching it at 40. French Bulldog owners already spend more on veterinary care than any other breed's owners. A monitoring device that detects early respiratory decline reduces emergency visits, improves treatment timing, and gives both the owner and the veterinarian actionable data between appointments.
Related Articles:
Dedicated to the design, development and production of pet tracking products.
Contact: Collin Hu
Contact number: +86 13823767765
Email: collin@purespet.com
WhatsApp: +86 13823657765
Company Address: 3rd Floor, Building 6, Nanyu Industrial Park, Dalang Street, Longhua District, Shenzhen, China.
Shenzhen PureS Technology Co., Ltd.